Log in to MyACC
General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Eidos, Inc(MODEST), Pfizer, Inc(SIGNIFICANT), Akcea, Inc(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: FoldRx Pharmaceuticals Inc.(SIGNIFICANT), Alnylam Inc(SIGNIFICANT)
Mathew S. Maurer, MD, FACC
Guidelines
JACC Journals on ACC.org
- JACC
- JACC: Cardiovascular Interventions
- JACC: Cardiovascular Imaging
- JACC Heart Failure
- JACC: Clinical Electrophysiology
- JACC: Basic to Translational Science
Membership
- About Membership
- Become a Member
- Renew Your Membership
- Member Benefits and Resources
- Member Sections
- Chapters
- Member Directory
About ACC
Clinical Topics
- Acute Coronary Syndromes
- Anticoagulation Management
- Arrhythmias and Clinical EP
- Cardiac Surgery
- Cardio-Oncology
- Chronic Angina
- Congenital Heart Disease and
Pediatric Cardiology - Diabetes and Cardiometabolic
Disease - Dyslipidemia
- Geriatric Cardiology
- Heart Failure and Cardiomyopathies
- Hypertriglyceridemia
- Invasive Cardiovascular Angiography
and Intervention - Noninvasive Imaging
- Pericardial Disease
- Prevention
- Pulmonary Hypertension and Venous
Thromboembolism - Sports and Exercise Cardiology
- Stable Ischemic Heart Disease
- Valvular Heart Disease
- Vascular Medicine
Latest in Cardiology
Education and Meetings
- Online Learning Catalog
- Understanding MOC
- Products and Resources
- Image and Slide Gallery
- Meetings
- Annual Scientific Session
Tools and Practice Support
- JACC
- Quality Improvement for Institutions
- NCDR
- CardioSmart
- MedAxiom
- Accreditation Services
- Contact Us
- Heart House
- 2400 N Street NW
- Washington DC, 20037
- Phone:
- (800) 253-4636, ext. 5603 or
(202) 375-6000, ext. 5603 - E-mail:
- resource@acc.org
- Fax:
- (202) 375-7000
